HSA IMCB Engagement Session

We recently held an engagement session between the Health Sciences Authority (HSA) and Institute of Molecular and Cell Biology (IMCB), A*STAR. This was an important opportunity to initiate early dialogue on the development and application of new approach methodologies (NAMs) in drug discovery.

Our discussion underscored the value of aligning scientific innovation with regulatory perspectives from the outset. Through open communication, we aim to anticipate regulatory considerations as we advance our research and translational capabilities. Moving forward, we hope to build a strong and sustained partnership with HSA.

Thanks to Adrian Teo and Hwee Hui Lau for helping organizing such a good session!